ARVN
Price
$7.68
Change
-$0.08 (-1.03%)
Updated
Aug 29, 03:49 PM (EDT)
Capitalization
569.72M
74 days until earnings call
SRPT
Price
$17.87
Change
-$0.47 (-2.56%)
Updated
Aug 29, 04:19 PM (EDT)
Capitalization
1.79B
61 days until earnings call
Interact to see
Advertisement

ARVN vs SRPT

Header iconARVN vs SRPT Comparison
Open Charts ARVN vs SRPTBanner chart's image
Arvinas
Price$7.68
Change-$0.08 (-1.03%)
Volume$114
Capitalization569.72M
Sarepta Therapeutics
Price$17.87
Change-$0.47 (-2.56%)
Volume$3.2K
Capitalization1.79B
ARVN vs SRPT Comparison Chart in %
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. SRPT commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Buy and SRPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ARVN: $7.76 vs. SRPT: $18.34)
Brand notoriety: ARVN: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 61% vs. SRPT: 38%
Market capitalization -- ARVN: $569.72M vs. SRPT: $1.79B
ARVN [@Biotechnology] is valued at $569.72M. SRPT’s [@Biotechnology] market capitalization is $1.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 1 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 1 green, 4 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, ARVN is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 4 TA indicator(s) are bullish while SRPT’s TA Score has 5 bullish TA indicator(s).

  • ARVN’s TA Score: 4 bullish, 6 bearish.
  • SRPT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than ARVN.

Price Growth

ARVN (@Biotechnology) experienced а +6.30% price change this week, while SRPT (@Biotechnology) price change was -8.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.09%, and the average quarterly price growth was +29.14%.

Reported Earning Dates

ARVN is expected to report earnings on Nov 11, 2025.

SRPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($1.79B) has a higher market cap than ARVN($570M). ARVN YTD gains are higher at: -59.520 vs. SRPT (-84.917). SRPT has higher annual earnings (EBITDA): 36.1M vs. ARVN (-112.6M). ARVN has more cash in the bank: 861M vs. SRPT (800M). ARVN has less debt than SRPT: ARVN (9.9M) vs SRPT (1.35B). SRPT has higher revenues than ARVN: SRPT (2.48B) vs ARVN (373M).
ARVNSRPTARVN / SRPT
Capitalization570M1.79B32%
EBITDA-112.6M36.1M-312%
Gain YTD-59.520-84.91770%
P/E RatioN/A27.21-
Revenue373M2.48B15%
Total Cash861M800M108%
Total Debt9.9M1.35B1%
FUNDAMENTALS RATINGS
ARVN vs SRPT: Fundamental Ratings
ARVN
SRPT
OUTLOOK RATING
1..100
184
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6465
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARVN's Valuation (14) in the Biotechnology industry is somewhat better than the same rating for SRPT (57). This means that ARVN’s stock grew somewhat faster than SRPT’s over the last 12 months.

ARVN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that ARVN’s stock grew similarly to SRPT’s over the last 12 months.

ARVN's SMR Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that ARVN’s stock grew similarly to SRPT’s over the last 12 months.

ARVN's Price Growth Rating (64) in the Biotechnology industry is in the same range as SRPT (65). This means that ARVN’s stock grew similarly to SRPT’s over the last 12 months.

ARVN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that ARVN’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARVNSRPT
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 17 days ago
74%
Declines
ODDS (%)
Bearish Trend 10 days ago
80%
Bearish Trend 11 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDDCX26.060.08
+0.31%
BlackRock Emerging Mkts Inv A
DNMDX29.26N/A
N/A
Dunham Monthly Distribution N
MPDRX11.21N/A
N/A
MassMutual Disciplined Gr R3
TRZRX16.20N/A
N/A
T. Rowe Price Real Assets Z
REMYX19.32-0.02
-0.10%
Russell Inv Emerging Markets Y

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-3.96%
AXON - ARVN
46%
Loosely correlated
+1.59%
VCYT - ARVN
46%
Loosely correlated
+4.68%
ERAS - ARVN
40%
Loosely correlated
-0.63%
ATXS - ARVN
40%
Loosely correlated
+0.31%
SRPT - ARVN
40%
Loosely correlated
+1.49%
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with ALZN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
+1.49%
ALZN - SRPT
49%
Loosely correlated
-1.22%
AXON - SRPT
43%
Loosely correlated
+1.59%
ARWR - SRPT
40%
Loosely correlated
+2.52%
SYRE - SRPT
40%
Loosely correlated
-2.45%
ARVN - SRPT
39%
Loosely correlated
-3.96%
More